Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
Current Medical Research and Opinion
|
September 19, 2007
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes
Alan G Wade, Ian Ford, Gordon Crawford, et al.
Clinical Interventions in Aging
|
June 28, 2014
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
Alan G Wade, Mildred Farmer, Gil Harari, et al.
Acta Pharmacologica Sinica
|
June 29, 2010
Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
Shao-wen Tian, Moshe Laudon, Li Han, et al.
The American Journal of Medicine
|
September 27, 2006
Melatonin reduces night blood pressure in patients with nocturnal hypertension
Ehud Grossman, Moshe Laudon, Ridvan Yalcin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
May 21, 2013
Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation
Thomas H Thatcher, Hsi-Min Hsiao, Elhanan Pinner, et al.
Biochimie
|
May 28, 2013
Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: role of ATGL and HSL
Ping-Ping Wang, Mei-Hua She, Ping-Ping He, et al.
Pharmacological Research
|
May 12, 2009
NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats
Meihua She, Xiaojian Deng, Zhenyu Guo, et al.
Neuropharmacology
|
July 19, 2015
Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models
Izaskun Buendia, Vanessa Gómez-Rangel, Laura González-Lafuente, et al.
Psychopharmacology
|
April 5, 2014
Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain
Yuan-Yuan Liu, Dou Yin, Li Chen, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
Current Medical Research and Opinion
|
September 19, 2007
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes
Alan G Wade, Ian Ford, Gordon Crawford, et al.
Clinical Interventions in Aging
|
June 28, 2014
Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial
Alan G Wade, Mildred Farmer, Gil Harari, et al.
Acta Pharmacologica Sinica
|
June 29, 2010
Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models
Shao-wen Tian, Moshe Laudon, Li Han, et al.
The American Journal of Medicine
|
September 27, 2006
Melatonin reduces night blood pressure in patients with nocturnal hypertension
Ehud Grossman, Moshe Laudon, Ridvan Yalcin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
May 21, 2013
Neu-164 and Neu-107, two novel antioxidant and anti-myeloperoxidase compounds, inhibit acute cigarette smoke-induced lung inflammation
Thomas H Thatcher, Hsi-Min Hsiao, Elhanan Pinner, et al.
Biochimie
|
May 28, 2013
Piromelatine decreases triglyceride accumulation in insulin resistant 3T3-L1 adipocytes: role of ATGL and HSL
Ping-Ping Wang, Mei-Hua She, Ping-Ping He, et al.
Pharmacological Research
|
May 12, 2009
NEU-P11, a novel melatonin agonist, inhibits weight gain and improves insulin sensitivity in high-fat/high-sucrose-fed rats
Meihua She, Xiaojian Deng, Zhenyu Guo, et al.
Neuropharmacology
|
July 19, 2015
Neuroprotective mechanism of the novel melatonin derivative Neu-P11 in brain ischemia related models
Izaskun Buendia, Vanessa Gómez-Rangel, Laura González-Lafuente, et al.
Psychopharmacology
|
April 5, 2014
Piromelatine exerts antinociceptive effect via melatonin, opioid, and 5HT1A receptors and hypnotic effect via melatonin receptors in a mouse model of neuropathic pain
Yuan-Yuan Liu, Dou Yin, Li Chen, et al.
Page
of 4